marijuana

Medical Marijuana Inc (OTCMKTS:MJNA) Closes At Key Level of $0.0999

Recently, Medical Marijuana Inc (OTCMKTS:MJNA) informed the shareholders that it appointed cannabis market veteran Dr. Stuart Titus as the new Chief Executive Officer of the company. After the news of change in management, the share prices surged more than 15%, providing a base to the declining stock. The optimism supported from the change in management was momentary as after one day of strong gains, the stock prices are on declining spree.

The view

The new CEO stated that he is excited and humbled to accept the new role of President and CEO of Medical Marijuana. He has seen the company translate from a small startup firm to a company with strong growth potentials. Medical Marijuana has developed a wide range of premium quality cannabis products. The product line also includes the world’s first CBD consumer product line. The launch of these products was revolutionary in the growing marijuana industry.

The offerings

Medical Marijuana products have helped many people to improve their quality of life. The customer’s perception towards cannabis products have changed significantly. It can be stated as the start of new trend in the industry. It is worth mentioning that as of now there as many as 23 U.S. states that have legalized medical marijuana. There are several others that are trying to get legalization status for medical marijuana. Although these states have approved use of medical marijuana, but still they are categorized under Schedule I drugs under the Federal Law.

The expo

Medical Marijuana Inc (OTCMKTS:MJNA) featured its entire range of products at the Natural Products Expo West that was organized in the first week of March. The medical cannabis may not be in the list of people attending the largest natural products expo. However, through the expo they will know the changing phase of marijuana industry.

In last trading session, MJNA stock prices surged 0.91% to close at $0.0999, with trading volume of 2.03 million.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyrıght 2015 traders350.com. All RIGHTS RESERVED.